Polypill Looks Good for Parkinson's

Fixed-dose product combining two standard drugs outperforms each alone in phase III

Related Keywords

New York ,United States ,American ,C Warren Olanow ,John Gever ,Icahn School Of Medicine At Mount Sinai ,American Academy Of Neurology ,Icahn School ,Mount Sinai ,American Academy ,Managing Editor ,